SCHEMBL19913312

SCHEMBL19913312

Cc1cc(C)cc(-c2ccc3c4ccccc4n(-c4cc(-c5cc(C)nc(C)c5)cc(-n5c6ccccc6c6ccc(-c7cc(C)cc(C)c7)cc65)c4C#N)c3c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 3/20 0.39
PDE9A O76083 1/20 0.35
PDE1C Q14123 1/20 0.35
KDM4A O75164 2/20 0.35
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 5/20 0.34
HPGD P15428 4/20 0.34
HSD17B10 Q99714 1/20 0.34
METAP2 P50579 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADORA2A P29274 3/20 0.32
ADORA1 P30542 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
PPARG P37231 1/20 0.32
NCOA2 Q15596 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913310 0.94 KDM5B (0.42) KDM5BKDM4AALDH1A1KDM4EHPGD
SCHEMBL19909436 0.93 KDM5B (0.40) KDM5BPDE9APDE1CKDM4AALDH1A1
SCHEMBL19913313 0.93 PDE9A (0.39) KDM5BPDE9APDE1CALDH1A1KDM4E
SCHEMBL23487672 0.92 KDM5B (0.37) KDM5BPDE9APDE1CKDM4AALDH1A1
SCHEMBL19913302 0.92 KDM4E (0.40) KDM5BPDE9APDE1CKDM4AALDH1A1
SCHEMBL19909228 0.90 PDE9A (0.35) KDM5BPDE9APDE1CALDH1A1KDM4E
SCHEMBL19909203 0.90 CHEK1 (0.38) ALDH1A1KDM4EHPGDHSD17B10METAP2
SCHEMBL19909204 0.90 METAP2 (0.33) ALDH1A1KDM4EHPGDHSD17B10METAP2
SCHEMBL19909132 0.90 PDE9A (0.37) PDE9APDE1CALDH1A1KDM4EHPGD
SCHEMBL19909065 0.89 ALDH1A1 (0.40) PDE9APDE1CALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 KDM5B 4454/4885PDE9A 2525/4885PDE1C 4780/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 KDM5B 4185/4885PDE9A 4739/4885PDE1C 4778/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 KDM5B 4454/4885PDE9A 2525/4885PDE1C 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.